1. Electrophoretic drug delivery for seizure control
- Author
-
Georgios Malliaras, Christopher M. Proctor, Adam Williamson, Christophe Bernard, Isabel del Agua, Andrea Slézia, Attila Kaszás, Antoine Ghestem, Anna-Maria Pappa, University of Cambridge [UK] (CAM), Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Bioelectronics, Ecole Nationale Supérieure des Mines, CMP-EMSE, MOC, Marie Curie Intra-European Fellowship for Career Development (no. 625372), ANR-11-IDEX-0001,Amidex,INITIATIVE D'EXCELLENCE AIX MARSEILLE UNIVERSITE(2011), European Project: 716867,ERC, bernard, christophe, INITIATIVE D'EXCELLENCE AIX MARSEILLE UNIVERSITE - - Amidex2011 - ANR-11-IDEX-0001 - IDEX - VALID, Epilepsy Controlled with Electronic Neurotransmitter Delivery - ERC - 716867 - INCOMING, Proctor, Christopher M [0000-0002-2066-1354], Kaszas, Attila [0000-0002-2019-3722], Ghestem, Antoine [0000-0002-6892-3245], Del Agua, Isabel [0000-0002-8751-5503], Pappa, Anna-Maria [0000-0002-7980-4073], Bernard, Christophe [0000-0003-3014-1966], Malliaras, George G [0000-0002-4582-8501], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,Drug ,[SDV.BIO]Life Sciences [q-bio]/Biotechnology ,GABA Agents ,media_common.quotation_subject ,Microfluidics ,02 engineering and technology ,Drug Drugs ,03 medical and health sciences ,Neural activity ,Epilepsy ,Mice ,Drug Delivery Systems ,Seizures ,Seizure control ,Medicine ,Local pressure ,Animals ,[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Health and Medicine ,gamma-Aminobutyric Acid ,Research Articles ,media_common ,Multidisciplinary ,business.industry ,SciAdv r-articles ,Rodent model ,021001 nanoscience & nanotechnology ,medicine.disease ,3. Good health ,[SDV.BIO] Life Sciences [q-bio]/Biotechnology ,Brain region ,030104 developmental biology ,Neurology ,Drug delivery ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,0210 nano-technology ,business ,Neuroscience ,Research Article - Abstract
An implantable microfluidic ion pump prevents seizures in a mice by delivery of inhibitory neurotransmitters to the seizure source., The persistence of intractable neurological disorders necessitates novel therapeutic solutions. We demonstrate the utility of direct in situ electrophoretic drug delivery to treat neurological disorders. We present a neural probe incorporating a microfluidic ion pump (μFIP) for on-demand drug delivery and electrodes for recording local neural activity. The μFIP works by electrophoretically pumping ions across an ion exchange membrane and thereby delivers only the drug of interest and not the solvent. This “dry” delivery enables precise drug release into the brain region with negligible local pressure increase. The therapeutic potential of the μFIP probe is tested in a rodent model of epilepsy. The μFIP probe can detect pathological activity and then intervene to stop seizures by delivering inhibitory neurotransmitters directly to the seizure source. We anticipate that further tailored engineering of the μFIP platform will enable additional applications in neural interfacing and the treatment of neurological disorders.
- Published
- 2018
- Full Text
- View/download PDF